Literature DB >> 2238754

Elimination of Helicobacter pylori under treatment with omeprazole.

M Stolte1, B Bethke.   

Abstract

Biopsies from the stomachs (antrum and corpus) of 201 patients with peptic ulcers or reflux oesophagitis were retrospectively investigated for the effect of treatment with omeprazole on the elimination of Helicobacter pylori (HP) and on gastritis. Of 64 patients without gastritis two (3.1%) developed gastritis during treatment. Among 134 patients with HP gastritis undergoing treatment, 48 (35.8%) experienced no HP elimination, in 41 (30.6%) there was HP elimination from the antrum, but HP persistence in the corpus, while in 45 (33.6%) HP was eliminated from both antrum and corpus. HP elimination led to a reduction in the degree and activity of gastritis under omeprazole treatment. Only eight patients were examined after completion of treatment, and in three in whom HP had been eliminated, recolonization was found to have occurred. The disappearance of HP in Type A gastritis coupled with the fact that HP is highly sensitive to contamination with other bacteria--as observed in the laboratory--suggests that this now partially established elimination of HP under the strongly acid-inhibiting omeprazole therapy can be traced back to a bacterial overgrowth of the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2238754

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  20 in total

1.  Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.

Authors:  J Labenz; B Tillenburg; U Peitz; E Verdú; M Stolte; G Börsch; A L Blum
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

3.  Gastric juice for the diagnosis of H pylori infection in patients on proton pump inhibitors.

Authors:  Javed Yakoob; Shahid Rasool; Zaigham Abbas; Wasim Jafri; Shahab Abid; Muhammad Islam; Zubair Ahmad
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

4.  Any role left for invasive tests? Histology in clinical practice.

Authors:  P Moayyedi; M F Dixon
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

5.  Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.

Authors:  J Labenz; E Gyenes; G H Rühl; G Börsch
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

6.  Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

Authors:  R P Logan; M M Walker; J J Misiewicz; P A Gummett; Q N Karim; J H Baron
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

7.  Eradication of Helicobacter pylori with clarithromycin and omeprazole.

Authors:  R P Logan; P A Gummett; H D Schaufelberger; R R Greaves; G M Mendelson; M M Walker; P H Thomas; J H Baron; J J Misiewicz
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

8.  Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations.

Authors:  G M Sobala; J E Crabtree; M F Dixon; C J Schorah; J D Taylor; B J Rathbone; R V Heatley; A T Axon
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

9.  Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease.

Authors:  J Labenz; G H Rühl; J Bertrams; G Börsch
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

10.  Helicobacter pylori requires an acidic environment to survive in the presence of urea.

Authors:  M Clyne; A Labigne; B Drumm
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.